Criteria to define rare diseases and orphan drugs: systematic review

Ghada Abozaid*, Katie Kerr, Amy McKnight, Hussain Alomar

*Corresponding author for this work

Research output: Other contribution

17 Downloads (Pure)

Abstract


Original languageEnglish
TypeSystematic Review Protocol Registraton
Media of outputPROSPERO Online Database
PublisherPROSPERO
Publication statusPublished - 13 Aug 2021

Bibliographical note

Ghada Abozaid, Katie Kerr, Amy McKnight, Hussain Alomar. Criteria to define rare diseases and orphan drugs: systematic review. PROSPERO 2021 CRD42021252701 Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021252701

Keywords

  • rare disease
  • orphan drug
  • medication
  • systematic review

Fingerprint

Dive into the research topics of 'Criteria to define rare diseases and orphan drugs: systematic review'. Together they form a unique fingerprint.

Cite this